Safety, Tolerability and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S Against COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT04569383

Recruitment Status : Not yet recruiting

First Posted : September 29, 2020

Last Update Posted : September 29, 2020

See Contacts and Locations

Sponsor:

Collaborators:

German Center for Infection Research

Philipps University Marburg Medical Center

Ludwig-Maximilians - University of Munich

Information provided by (Responsible Party):

Universitätsklinikum Hamburg-Eppendorf

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Not yet recruiting
Estimated Primary Completion Date :	May 2021
Estimated Study Completion Date :	May 2021

To Top